Matthew B. Boxer
Oprichter bij Veralox Therapeutics, Inc.
Profiel
Matthew B.
Boxer has founded Veralox Therapeutics, Inc. in 2017, where he holds the title of Chief Operating Officer & Director.
He was also a Vice President & Head-Translational Medicine at Rebus Holdings, Inc. in 2017.
Dr. Boxer holds a doctorate from The University of Chicago and an undergraduate degree from the University of Vermont.
Actieve functies van Matthew B. Boxer
| Bedrijven | Functie | Begin |
|---|---|---|
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Oprichter | 01-01-2017 |
Eerdere bekende functies van Matthew B. Boxer
| Bedrijven | Functie | Einde |
|---|---|---|
| REBUS HOLDINGS, INC. | Corporate Officer/Principal | 01-12-2017 |
Opleiding van Matthew B. Boxer
| The University of Chicago | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
